Novakand Pharma AB (publ) (STO:NOVKAN)
0.1268
+0.0022 (1.77%)
Feb 11, 2026, 10:50 AM CET
Novakand Pharma AB Employees
Novakand Pharma AB had 5 employees as of September 30, 2025. The number of employees did not change compared to the same quarter last year.
Employees
5
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-10.38M SEK
Market Cap
15.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 5 | 0 | - | 5 | 0 |
| Jun 30, 2025 | 5 | 0 | - | 5 | 0 |
| Mar 31, 2025 | 5 | 0 | - | 5 | 0 |
| Dec 31, 2024 | 5 | 2 | 66.67% | 5 | 0 |
| Sep 30, 2024 | 5 | 1 | 25.00% | 5 | 0 |
| Jun 30, 2024 | 5 | 1 | 25.00% | 5 | 0 |
| Mar 31, 2024 | 5 | 0 | - | 5 | 0 |
| Dec 31, 2023 | 3 | -2 | -40.00% | 3 | 0 |
| Sep 30, 2023 | 4 | -1 | -20.00% | 4 | 0 |
| Jun 30, 2023 | 4 | -2 | -33.33% | 4 | 0 |
| Mar 31, 2023 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2022 | 5 | -2 | -28.57% | 5 | 0 |
| Sep 30, 2022 | 5 | -2 | -28.57% | 5 | 0 |
| Jun 30, 2022 | 6 | -2 | -25.00% | 6 | 0 |
| Mar 31, 2022 | 7 | -1 | -12.50% | 7 | 0 |
| Dec 31, 2021 | 7 | -1 | -12.50% | 7 | 0 |
| Sep 30, 2021 | 7 | -2 | -22.22% | 6 | 1 |
| Mar 31, 2021 | 8 | - | - | 8 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nanologica AB | 19 |
| AcouSort AB | 16 |
| 2cureX AB | 14 |
| Guard Therapeutics International AB | 12 |
| Fluicell AB | 11 |
| Lipigon Pharmaceuticals AB | 7 |
| Aptahem AB | 3 |
| Stayble Therapeutics AB | 2 |